This study revealed that the lncRNA-HGBC/miR-502-3p/SET/AKT axis is important in GBC progression and proposes that lncRNA-HGBC could be a potential therapeutic target in the future [53]. This evidence concerns the gene SET and Hemoglobin C Measurement.